1-2 of 2
Mario Bargetzi
Close
Sort by
Journal Articles

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Clinical Trials & Observations
Bob Löwenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, Marinus van Marwijk Kooy, Marie-Christiane Vekemans, Walter J. F. M. van der Velden, Berna Beverloo, Lucienne Michaux, Carlos Graux, Dries Deeren, Okke de Weerdt, Joost W. J. van Esser, Mario Bargetzi, Saskia K. Klein, Alain Gadisseur, Peter E. Westerweel, Hendrik Veelken, Michael Gregor, Tobias Silzle, Daniëlle van Lammeren-Venema, Ine Moors, Dimitri A. Breems, Mels Hoogendoorn, Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjorn T. Gjertsen, Jeroen J. W. M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J. M. Valk, Catharina H. M. J. van Elssen, Markus G. Manz, Yngvar Floisand, Gert J. Ossenkoppele
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1110–1121.
https://doi.org/10.1182/bloodadvances.2020003855
Published: 2021
Includes: Supplemental data
Journal Articles

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial

Clinical Trials & Observations
Rudolf Benz, Kornelius Arn, Martin Andres, Thomas Pabst, Michael Baumann, Urban Novak, Felicitas Hitz, Urs Hess, Reinhard Zenhaeusern, Yves Chalandon, Ulrich Mey, Sabine Blum, Daniel Rauch, Alix O'Meara Stern, Nathan Cantoni, Mario Bargetzi, Elena Bianchi-Papina, Davide Rossi, Jakob Passweg, Andreas Lohri, Simona Berardi, Qiyu Li, Anita Feller, Georg Stussi
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3699–3707.
https://doi.org/10.1182/bloodadvances.2020002160
Published: 2020
Includes: Supplemental data